Form 4: uniQure Director Sells Shares After Option Exercise

uniQure N.V. Director Jack Kaye exercised stock options and subsequently sold 6,390 ordinary shares on January 9, 2026, under a pre-arranged 10b5-1 plan.

Summary

• Director Jack Kaye exercised 6,390 stock options for uniQure N.V. ordinary shares at an exercise price of $19.39 per share on January 9, 2026.
• Concurrently, Mr. Kaye sold 6,390 ordinary shares at a weighted average price of $27.28 per share, with individual transaction prices ranging from $27.19 to $27.39.
• These transactions were executed on January 9, 2026, pursuant to a Rule 10b5-1 sales plan adopted on June 16, 2025.
• Following these reported transactions, Mr. Kaye directly beneficially owns 20,439 ordinary shares of uniQure N.V.

Sentiment

Score: 6

Explanation: The filing reports a routine insider transaction where a director exercised options and sold shares under a pre-arranged plan, indicating personal financial planning rather than a direct statement on company performance. The director realized a profit from the transaction.

Positives

• Director Jack Kaye realized a profit from exercising options at $19.39 and selling shares at a weighted average price of $27.28.
• The transactions were conducted under a pre-arranged Rule 10b5-1 plan, indicating a structured and pre-determined sale rather than a reaction to immediate market conditions.

Negatives

• A director selling shares, even under a 10b5-1 plan, can sometimes be perceived as a lack of confidence by some investors, though it is often for personal financial planning and diversification.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing reports a routine insider transaction and does not provide information directly related to broader industry trends or competitive landscape.

Corporate Governance

Stakeholder Impact

• Shareholders may observe the director's share sale, which could be interpreted as a personal financial decision or, by some, as a signal regarding the company's prospects, although the 10b5-1 plan mitigates the latter interpretation.

Next Steps

• The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price within the reported range upon request to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission.

Key Dates

Recommendation

This Form 4 reports a pre-planned insider transaction involving the exercise of options and subsequent sale of shares by a director. While the director realized a profit, this type of transaction, especially under a 10b5-1 plan, is typically for personal financial management and does not inherently signal a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this filing.

Keywords

uniQure, QURE, Form 4, insider trading, stock options, share sale, director, beneficial ownership, 10b5-1 plan